No results for ‘’
Samrat Pharmachem Ltd
₹225.95
(0.67%)
Thu, 24 Sept 2026, 06:41 am
Process Industries
Chemicals: Specialty
24.5KSamrat Pharmachem PB Ratio
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 3.84 | 4.21 | 2.46 | 16.15 | 25.90 | 36.08 | 27.50 | 13.91 | 12.15 | 15.02 | 4.37 | 7.88 | 8.72 | 6.89 | 47.64 | 13.59 |
| Price to book ratio | 0.39 | 0.59 | 0.65 | 0.74 | 0.50 | 0.48 | 0.85 | 0.61 | 1.59 | 2.11 | 1.15 | 0.76 | 1.42 | 3.20 | 1.82 | 1.59 | 1.35 |
| Price to sales ratio | 0.07 | 0.10 | 0.13 | 0.13 | 0.09 | 0.10 | 0.24 | 0.13 | 0.34 | 0.42 | 0.21 | 0.13 | 0.23 | 0.68 | 0.37 | 0.37 | 0.34 |
| Price to cash flow ratio | 5.78 | 4.71 | 0 | 2.34 | 0 | 1.53 | 0 | 6.43 | 0 | 0 | 16.28 | 0 | 11.56 | 8.84 | 0 | 11.34 | 0 |
| Enterprise value | 1.87Cr | 2.91Cr | 5.78Cr | 8.26Cr | 8.23Cr | 5.03Cr | 10.68Cr | 8.39Cr | 24.19Cr | 44.49Cr | 27.35Cr | 26.74Cr | 48.27Cr | 143Cr | 121Cr | 102Cr | 106Cr |
| Enterprise value to EBITDA ratio | 4.22 | 1.51 | 2.40 | 1.38 | 7.63 | 8.35 | 9.13 | 7 | 6.54 | 7.57 | 8.67 | 4.06 | 5.40 | 5.85 | 5.02 | 36.10 | 9.94 |
| Debt to equity ratio | 0.38 | 0.22 | 0.22 | 0.27 | 0.35 | 0.24 | 0.24 | 0.40 | 0.45 | 0.51 | 0.33 | 0.39 | 0.30 | 0.16 | 0.30 | 0.13 | 0.14 |
| Return on equity % | 0 | 16.54 | 16.68 | 35.61 | 3.15 | 1.86 | 2.38 | 2.21 | 12.07 | 19 | 7.96 | 19.10 | 19.77 | 44.95 | 30.25 | 3.38 | 10.40 |
Samrat Pharmachem Ltd Price to Book Ratio
The Samrat Pharmachem Ltd Price to Book Ratio is a key financial metric used by investors to evaluate Samrat Pharmachem Ltd's valuation, profitability, and overall financial performance. Tracking the Samrat Pharmachem Ltd Price to Book Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Samrat Pharmachem Ltd (NSE: , BSE: 530125) is currently trading at ₹225.95, with a market capitalization of ₹69.35Cr. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Samrat Pharmachem Ltd Price to Book Ratio is essential for fundamental analysis.
Samrat Pharmachem Ltd Price to Book Ratio Current Value
The current Samrat Pharmachem Ltd Price to Book Ratio stands at 1.35.
The Samrat Pharmachem Ltd Price to Book Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Samrat Pharmachem Ltd Price to Book Ratio Historical Trend
The Samrat Pharmachem Ltd Price to Book Ratio has shown the following historical trend:
- 2024: 1.35
- 2023: 1.59
- 2022: 1.82
- 2021: 3.20
- 2020: 1.42
The decline in Samrat Pharmachem Ltd Price to Book Ratio indicates improving financial efficiency or better earnings growth.
What Samrat Pharmachem Ltd Price to Book Ratio Indicates for Investors
The Samrat Pharmachem Ltd Price to Book Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/B ratio shows how the market values company assets relative to book value.
Samrat Pharmachem Ltd Price to Book Ratio Analysis Summary
The Samrat Pharmachem Ltd Price to Book Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Samrat Pharmachem Ltd Price to Book Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Samrat Pharmachem Ltd Price to Book Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.